Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
17th May 20216:15 pmRNSHolding(s) in Company
14th May 20212:15 pmRNSResult of AGM
13th May 20219:00 amRNSDirector/PDMR Shareholding
30th Apr 202111:45 amRNSTotal Voting Rights
13th Apr 20211:00 pmRNSDirector/PDMR Shareholding
7th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 202112:00 pmRNSDirector/PDMR Shareholding
31st Mar 20212:00 pmRNSTotal Voting Rights
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
29th Mar 20214:40 pmRNSNotice of AGM
24th Mar 20214:15 pmRNSDirector/PDMR Shareholding
19th Mar 202111:30 amRNSDirector/PDMR Shareholding
18th Mar 202110:00 amRNSHolding(s) in Company
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20214:30 pmRNSDirector/PDMR Shareholding
8th Mar 20213:15 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNS2020 Annual Financial Results
26th Feb 20212:00 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPhoenix and SLA simplify Strategic Partnership
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
8th Feb 20216:00 pmRNSDirector/PDMR Shareholding
29th Jan 20213:30 pmRNSTotal Voting Rights
21st Jan 20214:45 pmRNSHolding(s) in Company
8th Jan 20213:10 pmRNSDirector/PDMR Shareholding
31st Dec 202011:00 amRNSTotal Voting Rights
29th Dec 202010:45 amRNSHolding(s) in Company
24th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20203:30 pmRNSBlock listing Return
11th Dec 20202:45 pmRNSDirector/PDMR Shareholding
9th Dec 20204:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSPhoenix Group Holdings plc - Trading Update
30th Nov 20204:00 pmRNSTotal Voting Rights
24th Nov 20207:00 amRNSStatement Regarding Press Speculation
6th Nov 20205:30 pmRNSDirector/PDMR Shareholding
6th Nov 20204:15 pmRNSDirector/PDMR Shareholding
30th Oct 202012:30 pmRNSTotal Voting Rights
28th Oct 20205:30 pmRNSDirector/PDMR Shareholding
28th Oct 202010:30 amRNSNotice of Delisting of Restricted Tier 1 Notes
27th Oct 20202:48 pmRNSNotice of Variation and Relisting of Notes
14th Oct 20209:40 amRNSHolding(s) in Company
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
6th Oct 202012:45 pmRNSDirector/PDMR Shareholding
1st Oct 20201:00 pmRNSDirector/PDMR Shareholding
30th Sep 202012:20 pmRNSTotal Voting Rights
25th Sep 202011:45 amRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.